Class III Medical Device: Documents and Rules Selected in ÜTS Registration

SUMMARY
A Class III medical device belongs to the highest of the four risk classes in the Medical Device Regulation. The class is determined by the rules in Annex VIII; conformity assessment is carried out through Annex IX, or through Annex X together with Annex XI.
In this article we give, through literal quotations (unofficial translations) from TİTCK ÜTS Registration Guideline TCKKD-KLVZ-03, the rules leading to Class III and how documents are associated in ÜTS registration. The document list is taken from the guideline's own table.
For ÜTS document registration of your Class III devices: Medical Device ÜTS Registration Consultancy
Contents
1. What Is a Class III Medical Device?2. Which Rules Lead a Device to Class III?3. Conformity Assessment for Class III4. Which Documents Are Associated with a Class III Device in ÜTS?5. Information Required in the EU Certificate and EU Declaration of Conformity6. Apostille, e-Signature and Sworn Translation7. Instructions for Use, Label and Product Images8. MDD-Certified Class III Devices: 31.12.20279. Frequently Asked Questions
1. What Is a Class III Medical Device?
“(1) Devices are classified as class I, IIa, IIb or III, taking into account the risks inherent in the intended purpose and nature of the devices. Classification is carried out in accordance with Annex VIII.”
The guideline states that devices under the MDR are classified according to a total of 22 rules in the categories "Non-invasive Devices", "Invasive Devices", "Active Devices" and "Special Rules" (Article 56, second paragraph). For the other classes, see our articles on Class I medical devices and Class IIa and IIb medical devices.
2. Which Rules Lead a Device to Class III?
Class III subparagraphs for Rule 6 (surgically invasive devices intended for transient use) and Rule 7 (surgically invasive devices intended for short-term use):
“If specifically intended to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with these parts of the body, they are classified as class III,”
“If specifically intended for use in direct contact with the heart, the central circulatory system or the central nervous system, they are classified as class III,”
Rule 7 also contains the following subparagraph:
“If they have a biological effect or are wholly or mainly absorbed, they are classified as class III,”
Rule 8 covers implantable devices and long-term surgically invasive devices:
“All implantable devices and long-term surgically invasive devices are classified as class IIb unless they:”
“If they are intended to be used in direct contact with the heart, the central circulatory system or the central nervous system, they are classified as class III,”
“If they have a biological effect or are wholly or mainly absorbed, they are classified as class III,”
“If they undergo chemical change in the body, except where the devices are placed in the teeth, they are classified as class III,”
“If they are intended to administer medicinal products, they are classified as class III,”
“If they are active implantable devices or their accessories, they are classified as class III,”
“If they are breast implants or surgical meshes, they are classified as class III,”
“If they are intended to be total or partial joint replacements, with the exception of ancillary components such as screws, wedges, plates and instruments, they are classified as class III, or”
“If they are spinal disc replacement implants or implantable devices that come into contact with the spinal column, with the exception of components such as screws, wedges, plates and instruments, they are classified as class III.”
Provisions in other rules resulting in Class III:
“All non-invasive devices consisting of a substance or a mixture of substances intended to be used in vitro in direct contact with human cells, tissues or organs taken from the human body or used in vitro with human embryos before their implantation or administration into the body are classified as class III.”
“All active devices intended to control, monitor or directly influence the performance of active implantable devices are classified as class III.”
“If they have an effect that may cause death or an irreversible deterioration of a person's state of health, such software is classified as class III,”
“All devices used for contraception or the prevention of the transmission of sexually transmitted diseases are classified as class IIb. However, if they are implantable devices or long-term invasive devices, they are classified as class III.”
“All devices manufactured utilising tissues or cells of human or animal origin, or their derivatives, which are non-viable or rendered non-viable, are classified as class III, except for devices manufactured utilising tissues or cells of animal origin, or their derivatives, which are non-viable or rendered non-viable, that are intended to come into contact with intact skin only.”
“Active therapeutic devices with an integrated or incorporated diagnostic function which significantly determines the patient management by the device, such as closed loop systems or automated external defibrillators, are classified as class III.”
Devices incorporating a medicinal product under Rule 14 are also Class III. Rule 19 (nanomaterial) and Rule 21 (devices composed of substances that are absorbed) result in Class III in certain subparagraphs. For all the rules, see our article on the MDR risk class.
3. Conformity Assessment for Class III
“(3) Manufacturers of class III devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Annex IX. Alternatively, the manufacturer may choose to apply a conformity assessment as specified in Annex X coupled with a conformity assessment as specified in Annex XI.”
This provision is in Article 52 of the Medical Device Regulation (Article 52 of the MDR). The guideline also lists additional procedures for Class III implantable devices, devices incorporating a medicinal product and devices incorporating tissue of human or animal origin (Article 61, tenth to twelfth paragraphs).
4. Which Documents Are Associated with a Class III Device in ÜTS?
“(8) For devices to be registered in ÜTS under the MDR as "Class-III", the appropriate one of the ÜTS document business rules shown in Annex-93 is carried out.”
The guideline's Annex-93 table ("ÜTS Document Business Rules under the MDR (Class-III)") separates the documents as follows:
Mandatory documents: EU Declaration of Conformity, EU Certificate and Instructions for Use (1 piece).
EU certificate options: certificates annexed with "ANNEX IX (CHAPTER I&III) QUALITY MANAGEMENT SYSTEM ASSESSMENT" and "ANNEX IX (CHAPTER II) TECHNICAL DOCUMENTATION ASSESSMENT"; or a certificate annexed with "ANNEX-X TYPE EXAMINATION" together with a certificate annexed with "ANNEX XI (PART A) PRODUCTION QUALITY ASSURANCE" or "ANNEX XI (PART B) PRODUCT VERIFICATION".
Optional documents: Quality Management Certificate ISO 13485, Authorized Distributorship Certificate, Domestic Goods Certificate, Technical File and Catalog.
The documents are first brought to "Registered" status through separate document applications and then selected in the device registration:
“2) The documents to be added in accordance with the appropriate one of the document business rules mentioned in Article 66 of this Guideline, according to the risk class of the relevant device, are added to this field by selecting from among the documents that are currently registered in ÜTS as a result of the application made under Article 39 of this Guideline.”
For details of document types, see our page on ÜTS document types; for a summary by class, see our page on Class III documents.
5. Information Required in the EU Certificate and EU Declaration of Conformity
The subparagraph on device identification among the fields checked in the EU certificate:
“1) For EU technical documentation assessment certificates, EU type-examination certificates and EU product verification certificates; a clear identification of the device or devices, including name, model and type, as included by the manufacturer in the instructions for use, and the intended purpose, risk class and Basic UDI-DI relating to the conformity assessment procedure to which the device is subject,”
The guideline states the following on the validity of the certificate:
“(3) EU certificates issued under the new Medical Device Regulations remain valid for the period stated in the certificate, not exceeding 5 years, and as long as no change or update is made to the certificate during this period.”
“(6) The EU certificate must be uploaded and submitted to the Agency completely, together with all its annexes and additional pages.”
The notified body information is also required in the EU declaration of conformity of a Class III device:
“ı) For EU declarations of conformity other than those covering only Class-I Other or Class A devices: the name and identification number of the notified body, a description of the conformity assessment procedure performed, and the identification of the EU certificate or EU certificates issued (certificate number or numbers),”
6. Apostille, e-Signature and Sworn Translation
When the EU declaration of conformity of a foreign manufacturer is registered by the importer, the apostille-certified copy, the copy certified by the embassy/consulate of the Republic of Türkiye, the e-Apostille-certified original or the e-signed original is uploaded to the "Original Document" field (Article 12, first paragraph). Condition for an e-signed document:
“ç) For documents electronically signed (e-signed) by the manufacturer, the original of the relevant e-signed document, provided that it can be verified through e-signature verification tools/data that the document was electronically signed by its manufacturer, that the e-signature is valid, and that no change has been made to the document afterwards,”
2026/KKB-2 update: With TİTCK's Announcement No. 2026/KKB-2 dated 02.11.2026, a new route was introduced in place of the option of uploading the manufacturer's e-signed original of the declaration of conformity and SPP declaration of a foreign manufacturer:
“it has been decided to implement the option of uploading the relevant document to the relevant field in ÜTS, together with an undertaking electronically signed, by the authorized representative of the importer company authorized by the foreign manufacturer, with an e-signature (secure e-signature) created on the basis of a qualified electronic certificate obtained from an electronic certificate service provider recognized by Türkiye.”
Source: TİTCK Announcement No. 2026/KKB-2. For the required documents and steps, see our ÜTS document registration guide.
For an EU certificate issued by a foreign notified body, similar options are listed in Article 8; these include the e-signed original of the notified body's certificate and a certificate that can be verified on the body's query site or in EUDAMED. The translation rule:
“(2) Where the condition mentioned in the first paragraph of this Article exists, the complete Turkish translation, made by a sworn translator, of the document uploaded to the "Original Document" field is uploaded to the "Turkish Document" field.”
For details, see our medical device apostille guide.
7. Instructions for Use, Label and Product Images
Uploading the instructions for use is mandatory for Class III devices:
“1) For Class-III and Class-IIb devices, the instructions for use prepared by the manufacturer,”
If the instructions for use were not prepared in Turkish by the manufacturer, the latest original instructions for use are uploaded to the "Original Document" field and their Turkish translation to the "Turkish Document" field (Article 18).
For the label, the original market placement label is uploaded. If the original label is not in Turkish, ÜTS itself generates the Turkish label:
“Thus, companies do not upload a Turkish label separately. For this reason, it is important that the information on the product is entered into ÜTS correctly.”
Rules for product images:
“4) The catalog itself or an image containing more than one device that makes the device difficult to understand is not uploaded as a product image.”
“7) A maximum of 10 (ten) product images can be uploaded to this field.”
“If unclear and unreadable images are uploaded, the application is concluded negatively.”
Shelf life is not a separate document; it is a field in the device registration:
“2) This field is selected as "Yes" if the relevant device has a shelf life, and "No" if it has no shelf life.”
For all fields, see our pages on mandatory fields of ÜTS device registration and ÜTS product image and label rules.
8. MDD-Certified Class III Devices: 31.12.2027
“(4) Provided that the conditions specified in the Regulation referred to in the first paragraph of this Article are fulfilled, Class-III devices under the MDD or AIMDD and Class-IIb implantable devices, excluding sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors, may be placed on the market or put into service until 31.12.2027.”
This date comes from Regulation (EU) 2023/607 (Article 45). To benefit from the transition, an EBS application is made first, then an ÜTS application:
“(7) In order for companies to benefit from the MDR transition provisions for their devices within the scope of the third to sixth paragraphs of this Article, they must first apply through EBS under Article 46 of this Guideline; then, if the application they made in EBS is found appropriate by the Agency, they must make device (and/or document) registration/update applications in ÜTS for the relevant devices and their related documents under Article 47 of this Guideline.”
In the EBS application, the manufacturer's declaration that the extension conditions are met and the document of the notified body competent under the MDR are submitted with the document type "2023/KK-1 Extension Application" (Article 46). For the timeline, see our articles on the Regulation (EU) 2023/607 MDR transition timeline and the end of the transition on 31 December 2027.
For the steps of document and device registration, see our ÜTS registration guide; for the code requested at registration, our article on what a GMDN code is; and for having the registrations carried out on your behalf, our ÜTS consultancy page.
9. Frequently Asked Questions
Which documents are mandatory in ÜTS for a Class III medical device?
According to the guideline's Annex-93 table, the mandatory documents are the EU Declaration of Conformity, the EU Certificate and the Instructions for Use. ISO 13485, Authorized Distributorship Certificate, Domestic Goods Certificate, Technical File and Catalog are in the optional documents column.
Can an e-signed declaration of conformity be uploaded without an apostille?
Yes. Under Article 12 of the guideline, if it can be verified that the e-signature is valid and that no change was made to the document afterwards, the original of the e-signed document is uploaded. The sworn translation of a foreign-language document is added to the "Turkish Document" field.
Do I need to upload a Turkish label?
If the original label is not in Turkish, no. The original label is uploaded, and ÜTS generates the Turkish label template itself from the information entered.
Is a separate document required for shelf life?
In the guideline, shelf life is not a document type but the "Has shelf life?" field in the device registration. If there is a shelf life, the period is entered and must be consistent with the information on the label.
Until when can an MDD-certified Class III device be placed on the market?
Until 31.12.2027, provided that the conditions in Regulation (EU) 2023/607 are fulfilled. For this, an extension application is made first in EBS and then an ÜTS application.
For ÜTS document and device registration of your Class III devices: Medical Device ÜTS Registration Consultancy
Sources
TİTCK: ÜTS Registration Guideline TCKKD-KLVZ-03, Articles 7, 8, 11, 12, 17, 18, 27, 45, 46, 56, 61 and 66, Annex-93
Mevzuat.gov.tr: Medical Device Regulation, Articles 51 and 52, Annex VIII
EUR-Lex: Regulation (EU) 2017/745 (MDR)
EUR-Lex: Regulation (EU) 2023/607



